Overview

Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia

Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The study aims to assess the activity of decitabine in the treatment of CMML.
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione Italiana Sindromi Mielodisplastiche Onlus
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Collaborator:
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
Treatments:
Azacitidine
Decitabine